No black box warning on record for Ursodiol 200 Mg

As of the latest FDA labeling reviewed, Ursodiol 200 Mg (USODIOL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ursodiol 200 Mg medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Enteroliths in Patients with Risk for Intestinal Stenosis or Stasis. There have been rare postmarketing reports of ursodiol-treated patients who developed enteroliths (bezoars) resulting in obstructive symptoms that required surgical intervention. These patients had medical conditions that predisposed them to intestinal stenosis or stasis (e.g., surgical enteroanastomosis, Crohn’s disease

No black box warning on record for Ursodiol 200 Mg

Other warnings & precautions

WARNINGS Enteroliths in Patients with Risk for Intestinal Stenosis or Stasis. There have been rare postmarketing reports of ursodiol-treated patients who developed enteroliths (bezoars) resulting in obstructive symptoms that required surgical intervention. These patients had medical conditions that predisposed them to intestinal stenosis or stasis (e.g., surgical enteroanastomosis, Crohn’s disease

Ursodiol 200 Mg Black Box Warning

No black box warning on record for Ursodiol 200 Mg

Other warnings & precautions

Ursodiol 200 Mg Black Box Warning

No black box warning on record for Ursodiol 200 Mg

Other warnings & precautions